Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
DNP Selectome Fund's Sloan Ratio for the quarter that ended in Apr. 2026 was 0.00%.
As of Apr. 2026, DNP Selectome Fund has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
DNP Selectome Fund (NYSE:DNP) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Apr. 2026, DNP Selectome Fund has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
DNP Selectome Fund Sloan Ratio % Related Terms
DNP Selectome Fund Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for DNP Selectome Fund's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, DNP Selectome Fund's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DNP Selectome Fund Sloan Ratio % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, DNP Selectome Fund's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where DNP Selectome Fund's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
DNP Selectome Fund's Sloan Ratio for the fiscal year that ended in Oct. 2025 is calculated as
For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data.
DNP Selectome Fund's Net Income for the trailing twelve months (TTM) ended in Apr. 2026 was 157.825 (Oct. 2025 ) + 543.064 (Apr. 2026 ) = $700.9 Mil.
DNP Selectome Fund's Cash Flow from Operations for the trailing twelve months (TTM) ended in Apr. 2026 was 114.96 (Oct. 2025 ) + 147.317 (Apr. 2026 ) = $262.3 Mil.
DNP Selectome Fund's Cash Flow from Investing for the trailing twelve months (TTM) ended in Apr. 2026 was 0 (Oct. 2025 ) + 0 (Apr. 2026 ) = $0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DNP Selectome Fund (DNP) has a Sloan Ratio % of 0.00% as of Apr. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on DNP Selectome Fund and its competitors.
Is DNP Selectome Fund's Sloan Ratio % too high?
DNP Selectome Fund's current Sloan Ratio % is 0.00%. Overall, DNP Selectome Fund has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does DNP Selectome Fund's Sloan Ratio % compare to CNS and FHI?
DNP Selectome Fund's Sloan Ratio % of 0.00% can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for an Asset Management company?
A good Sloan Ratio % depends on the Asset Management industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on DNP Selectome Fund and its competitors. DNP Selectome Fund's current Sloan Ratio % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DNP Selectome Fund stock overvalued right now?
DNP Selectome Fund (DNP) has a current Sloan Ratio % of 0.00%. The current Sloan Ratio % is 0.00%. DNP Selectome Fund's overall GF Score™ is 33/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For DNP Selectome Fund (DNP), the current Sloan Ratio % is 0.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
DNP Select Income Fund Inc is a closed-ended investment management fund. Its investment objectives are current income and long-term growth of income, with capital appreciation as a secondary objective. The Fund seeks to achieve its investment objectives by investing mainly in a diversified portfolio of equity and fixed-income securities of companies in the public utilities industry. Under normal market conditions, more than 65% of the Fund's total assets are invested in securities of public utility companies engaged in the production, transmission, or distribution of electric energy, gas, or telephone services.
33GF Score
Get the complete analysis for DNP
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DNP has been successfully added to your 
